Dr. Singh is a Professor of Human Genetics and Pediatrics and Director of the Genetic Metabolic Nutrition Program at Emory University School of Medicine in Atlanta, Georgia, USA. With over 25 years of research and clinical experience in the field of inborn errors of metabolism (IEM), her clinical research interest focuses on the efficacy of restrictive diets and genotype/phenotype relationships.
Her primary career interests have included maximizing the benefits of the early identification through newborn screening (NBS) and pre-symptomatic treatment with diets to improve health outcomes in children with IEM. She has led nationally recognized efforts in developing translational clinical research.
She is PI of the HRSA/MCHB (Health Resources and Services Administration/Maternal and Child Health Bureau) funded project “Enhanced Genetic Services and Newborn Screening Collaborative in Region 3” to identify gaps in genetic services, has served on the Board of the Society for Inherited Metabolic Disorders and served as the President of the Southeastern Regional Genetics Group (SERGG).
She is the founding President of the Genetic Metabolic Dietitians International (GMDI), is the leading Co-PI for the evidence based Nutritional Management Guidelines for Inherited metabolic disorders Project. She also served as the Chair for the nutrition section of the PKU Scientific Review Committee (State of the Science and Future Research Needs) of the National Institute of Health.
Dr. Singh is developing and leading efforts to create research-based programmatic interventions for patients with inherited metabolic disorders (IMDs) that result in optimal outcomes, including Medical Nutrition Therapy for Prevention (MNT4P) Program, primarily funded through the Georgia Department of Public Health and serves as the Co-Director of the Bio nutrition Research Unit of the Georgia Clinical and Translational Science Alliance (Georgia CTSA).